about
Comparison of the molecular mass and optical properties of colored dissolved organic material in two rivers and coastal waters by flow field-flow fractionationPrevalence in the United States of selected candidate gene variants. Third National Health and Nutrition Examination Survey, 1991- 1994Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention StudyUpdate: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection — United States, February 2016Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection — United States, 2016Case-control study of self reported genitourinary infections and risk of gastroschisis: findings from the national birth defects prevention study, 1997-2003Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric CliniciansCost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016Maternal febrile illnesses, medication use, and the risk of congenital renal anomaliesSevere Neurologic Disorders in 2 Fetuses with Zika Virus Infection, ColombiaBaseline Prevalence of Birth Defects Associated with Congenital Zika Virus Infection — Massachusetts, North Carolina, and Atlanta, Georgia, 2013–2014Vital Signs: Update on Zika Virus–Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure — U.S. Zika Pregnancy Registry, 2016Zika Virus Disease: A CDC Update for Pediatric Health Care Providers.Sharing prescription medication among teenage girls: potential danger to unplanned/undiagnosed pregnancies.Editorial perspectives from the founding CDC leadership of the National Birth Defects Prevention study.Birth defects among infants born to women who received anthrax vaccine in pregnancy.Diabetes mellitus and birth defects.Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders.Infection control assessment after an influenza outbreak in a residential care facility for children and young adults with neurologic and neurodevelopmental conditions.A national action plan for promoting preconception health and health care in the United States (2012-2014)Challenges in Studying Modifiable Risk Factors for Birth DefectsVasoactive exposures during pregnancy and risk of microtia.From genetics to genomics: using gene-based medicine to prevent disease and promote health in children.Editorial utility of population-based birth defects surveillance for monitoring the health of infants and as a foundation for etiologic research.Lack of periconceptional vitamins or supplements that contain folic acid and diabetes mellitus-associated birth defects.The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?Pregnancy Outcomes After Maternal Zika Virus Infection During Pregnancy - U.S. Territories, January 1, 2016-April 25, 2017.Serial Head and Brain Imaging of 17 Fetuses With Confirmed Zika Virus Infection in Colombia, South America.Description of 13 Infants Born During October 2015-January 2016 With Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil.Update: Interim Guidance for the Evaluation and Management of Infants with Possible Congenital Zika Virus Infection - United States, August 2016.Storage and use of residual dried blood spots from state newborn screening programs.Ascertaining the Burden of Birth Defects.Response to correction of refractive errors and hypoaccommodation in children with congenital Zika syndrome.Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.The safety or risk of antihistamine use in pregnancy: reassuring data are helpful but not sufficient.Maternal nutrition and gastroschisis: findings from the National Birth Defects Prevention Study.Prevalence, family history, and prevention of reported osteoporosis in U.S. women.Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.Folic acid use and nonsyndromic orofacial clefts in China: a prospective cohort study.Can we ensure the safe use of known human teratogens? Introduction of generic isotretinoin in the US as an example.
P50
Q22330803-960D7C56-79E2-406B-B64F-48D1703D0E77Q23917519-5324E0A4-C6DE-4564-9530-0A60F6F886EDQ23919551-70A1A7E1-D18F-4AEA-B214-3ED5919BF6DAQ24261161-9C5090A0-FA0A-4E14-8746-F7133512754FQ24261166-0120CC56-D160-4E8E-915E-AF241827A7C6Q24652682-32666D03-E804-4A07-AB38-75C8C6786759Q27682414-47A1D166-6931-4E76-9811-3395E177BB3EQ28119757-6AB89D2D-7D76-4321-AEC2-B190F11D6788Q28166959-A338D26E-F26B-4925-9D87-9FB7D27C902EQ28950453-7FD21C4E-D3BD-49E6-AB5D-6A2E9F4CAAC3Q28956693-4B434DF2-C5AB-4C82-8545-5A77CC123AD5Q29168666-F95CEF04-CD3A-4135-9DF8-53A2F30ED263Q30152152-32665B4E-DA9B-4264-BF37-9BBA12660C73Q33186889-8616051F-40D5-4E36-AF99-329A71F491D8Q33910872-5CAC5DF9-4B00-4EDF-A5FD-9F21E2E86C69Q34792025-437D7E20-65A3-417B-9A5B-599A3F50211AQ34803469-58D93E2F-4477-4394-B6F7-32DDF6949004Q35629524-E5E8C23B-D8E7-4349-B18F-E6C5C651C7A5Q35669930-457A8710-B639-4D8E-846C-F7DD5E3E998DQ35780139-583D1FE6-77AC-4355-9C3C-EB9B77B39842Q35894122-54F5222C-C680-401F-B756-3C4D0336A8AEQ35906721-78EF88F0-ED98-4FB7-9D62-3903877623D9Q36237428-5764226F-C17C-49D2-9B3F-CC1D7571A52EQ36379553-166A7F48-33DE-4D3E-BCF2-49C8E1E51FEBQ37025015-F20F5E30-A227-4702-B02C-332C44FF12A3Q37029751-B987DE36-88FB-402A-96E5-5F2FCF3E86C9Q38158807-AE9D7BF9-2452-4CB0-86E5-CF551FA696ACQ38159002-D4C6EA91-63B6-4132-AD69-862A1CE8D4D4Q40052107-532A61AC-58F8-4AB7-88A8-60C0C1D4C6D5Q40055517-2B9580FA-9705-4343-B901-9DFD0CE0AF07Q40320418-560B9865-39C4-4352-83D8-B4A5DC5145DBQ42809675-13FB21D1-0A85-481F-9294-D6A2D6A54F36Q43047150-2E4BF907-61D7-4711-9D8E-9F04A7E8F46FQ43047298-03611759-BFA4-4613-AEC4-1CC288FC5236Q43079101-49E21AA2-0201-43FF-A686-F9713E8281A6Q43467479-66AC2C53-1567-405B-BC9A-19033B3635A5Q44473596-63765516-A419-4685-ACC0-4A9D2FB0DEF9Q44580295-52E558F9-6B5A-4CB7-86B3-445EEA434FE0Q44978066-B8375D62-F3EA-481A-9C71-05C1F161846DQ45156781-B6E371CD-C7E1-4328-A7B0-B31CA1655F9A
P50
description
onderzoeker
@nl
name
Cynthia A. Moore
@en
Cynthia A. Moore
@es
Cynthia A. Moore
@sl
type
label
Cynthia A. Moore
@en
Cynthia A. Moore
@es
Cynthia A. Moore
@sl
prefLabel
Cynthia A. Moore
@en
Cynthia A. Moore
@es
Cynthia A. Moore
@sl
P106
P2038
Cynthia_Moore3